LONDON, ONTARIO--(MARKET WIRE)--Aug 15, 2007 -- Stellar Pharmaceuticals Inc. (CDNX:SLX.V - News) (OTC BB:SLXCF.OB - News) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the second quarter ended June 30, 2007. All amounts in this press release are in Canadian dollars, rounded to the nearest hundredth dollar and are the result of the use of U.S. generally accepted accounting principles.
